Website Exsera BioLabs is a CAP/CLIA-certified niche laboratory specializing in autoimmune and complement testing, all conducted in compliance with FDA GxPs. They provide esoteric testing to support diagnostics and biomarker translation, with a strong focus on both autoimmune diseases and complement-related conditions. Their collaborations with researchers, biotech, and pharmaceutical companies help advance scientific discoveries and…
Website OXcan (Oxford Cancer Analytics) is revolutionizing cancer detection starting from lung cancer by developing blood-based diagnostics for cancer identification, especially at the early stage, when treatment with curative intent may still be possible.
Website Cobio Diagnostics is a life sciences biotechnology company dedicated to the development and commercialization of rapid, next-generation, phage-amplified diagnostics for bacterial ID and phenotypic detection of antibiotic resistance.
Website Rapid, inexpensive, universal, on-site, pan-cancer monitoring of therapy effectiveness; ultimately an inexpensive, universal, pan-cancer screening test. Early identification of hyper-progressive disease or any inactive therapy and switching to an effective therapy can be lifesaving!
Website Starlyte Bio aims to push diagnostic technology into the next generation by illuminating the whole picture across diseases using the full chromatin structure that defines the disease state. This will provide insights into health and disease like never before.
Website Vega Surgical combines the efficacy of the operating room with the efficiency of a bedside procedure, significantly decreasing cost and, more importantly, improving patient outcomes. Vega will treat what will soon be the most common cranial neurosurgical disorder, Chronic Subdural Hematomas (CSDH), with the Xcape port and Axis Drill. Today, CSDHs are treated in…
Website Vitan-Biotech specializes in the development and commercialization of breakthrough life science instrumentation, novel biosensing systems, and diagnostic devices. Vitan is developing novel cancer diagnostic devices, platforms for glycan biomarker discovery, and disposable biosensors for pathogen detection, including assay development services: Biochips for detecting multiple serum cytokines and cancer biomarkers; Point-of-care devices for Circulating Tumor…
Website PharmaLogic is a North American radiopharmaceutical and Mobile PET/CT operations company, dedicated to nuclear medicine and the science of radiopharmaceutical production. Their commitment to these fields extends to the communities they serve. They further differentiate by offering a unique suite of solutions addressing the dynamic challenges facing the nuclear imaging market. PharmaLogic utilizes a…
Website Peak Diagnostic Partners offers a line of diagnostic tests using proprietary NextGen Sequencing technology to screen complex chronic diseases and provide Precision Medicine for the patient. Peak’s ReliefSeq® line of assays profiles conditions in days that normally take months or years to accurately diagnose. The Peak Dx AsthmaID® test provides physicians a comprehensive picture…
Website IMD Path is a Molecular Diagnostics laboratory investing in the technology, information systems, and business infrastructure to enable community-based pathology groups in their diagnostic mission and empower oncologists in both first line and advanced-stage cancer management of patients.